Johnson & Johnson has received FDA approval to promote Invega Sustenna as a drug that could potentially reduce the risk of incarceration for people with schizophrenia. Read more.
https://www.flmhlaw.com/wp-content/uploads/2018/02/syringe-pills.jpeg 2400 4000 Faith Sills, LCSW, CBHCMS http://www.flmhlaw.com/wp-content/uploads/2017/01/flmhlaw-logo-300x31.png Faith Sills, LCSW, CBHCMS2018-02-19 11:04:072023-03-08 22:37:24A Drug Company Says This Shot Will Keep You Out of Prison – The Marshall Project
You might also like
Webinar: Fetal Alcohol Spectrum Disorder (FASD) and the Criminal Justice System: From Arrest to Community Supervision, March 2
FREE Webinar: Considerations for Forensic Interviews with Vulnerable Adults – November 15 at 1:00 PM